grant

Developing Relaxin Peptides as Novel Therapies for Fibrosis [ 2013 - 2018 ]

Also known as: Developing Novel Therapies for Fibrosis

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1041766]

Researchers: A/Pr Chrishan Samuel (Principal investigator)

Brief description I am a matrix biologist determining the molecular mechanisms and novel therapeutic targets for fibrosis (tissue scarring). In particular, my research, which has a strong translational focus, is involved with elucidating the anti-fibrotic potential of the relaxin peptide-hormones (either alone or as an adjunct therapies to existing/other novel treatments) – as a means of developing therapeutic strategies for the treatment of cardiac and renal fibrosis.

Funding Amount $AUD 751,293.37

Funding Scheme Research Fellowships

Notes Research Fellowship

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]